Edition:
United States

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

593.25INR
24 Mar 2017
Change (% chg)

Rs-3.30 (-0.55%)
Prev Close
Rs596.55
Open
Rs592.65
Day's High
Rs597.75
Day's Low
Rs591.50
Volume
212,311
Avg. Vol
103,186
52-wk High
Rs621.90
52-wk Low
Rs458.25

Latest Key Developments (Source: Significant Developments)

Cipla Ltd says JV Partner gets orphan drug status in EU for stem cell drug
Monday, 1 Jun 2015 05:53am EDT 

Cipla Ltd:Says Stempeutics receives orphan drug designation in the European union for its novel stem cell drug stempeucel.  Full Article

Cipla Ltd board recommends dividend
Friday, 29 May 2015 08:55am EDT 

Cipla Ltd:Recommended payment of dividend of 2 Indian rupees per equity share (face value 2 Indian rupees per equity share) for the year 2014-1.Dividend, subject to the approval of shareholders, will be dispatched / credited on or after Sept. 01.  Full Article

Cipla Ltd's Cipla EU to acquire Duomed Produtos-Business Standard
Thursday, 9 Apr 2015 02:12am EDT 

Cipla Ltd:Said its UK subsidiary Cipla EU Ltd will acquire Brazilian firm Duomed Produtos Farmaceuticos for about 26 mln Indian Rupees-Business Standard.The deal has the approval of Brazilian health authority (ANVISA) and other regulatory authorities to import and distribute pharmaceutical products in Brazil, the filing said.The transaction is expected to be completed by end of May 2015.  Full Article

More From Around the Web

BRIEF-Cipla launches Hepatitis B vaccine in India

* Says Cipla launches Hepatitis B vaccine in India Source text - (http://bit.ly/2lUwkV6) Further company coverage: